From the 122 subjects, a total of 262 endometriosis lesions were sampled for the KRAS mutation assay based on our selective sampling strategy: 105 DIE samples, 44 OMA samples, and 113 SUP samples (supplementary material, Table S5). The gene discussed is KRAS; the disease is endometriosis.